Drug Trial Radar · NCT05398848
Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)
Last checked: Nov 19, 2026Latest source record: Feb 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,623
Actual
Start
Oct 31, 2022
Primary completion
Sep 4, 2023
Study completion Dec 29, 2023
Sponsor
- Lead sponsor
- Jiangsu Rec-Biotechnology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 1, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a multicenter designed Phase III clinical trial. About 10000 participants plan to be enrolled.The objectives of this study are to evaluate the efficacy, safety and immunogenicity of the recombinant two-component COVID-19 vaccine (CHO cell) in adults
Conditions
- COVID-19
Interventions
Recombinant two-component COVID-19 vaccine (CHO cell)Biological
Before reconstitution: Lyophilized powder for reconstitution in single-use vials After reconstitution with BFA03 adjuvant: Milk-white solution with no visible foreign matter
PlaceboBiological
Before reconstitution: Lyophilized powder for reconstitution in single-use vials After reconstitution with BFA03 adjuvant: Milk-white solution with no visible foreign matter
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of ReCOV in preventing Reverse Transcription-Polymerase Chain Reaction (RT-PCR) confirmed symptomatic COVID-19 in adultsTime frame: > 14 days after 3 doses vaccination.
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
B.P. Koirala Institute of Health Sciences
Dharān, Nepal
Aramil City Hospital
Aramil, Russia
LLC Medical Service solutions
Izhevsk, Russia
'Federal State Budgetary Scientific Institution "Russian Scientific Centre of Surgery named after academician B.V. Petrovsky"
Moscow, Russia
'Joint Stock Company "Clinical and diagnostic center "Euromedservice"
Moscow, Russia
State Regional Budgetary Institution of Healthcare "Murmansk Regional Clinical Hospital named after P.A. Bayandin"
Murmansk, Russia
LLC Professorskaya klinika
Perm, Russia
UZI 4D Clinic LLC
Pyatigorsk, Russia
Klinika Zvyezdnaya LLC
Saint Petersburg, Russia
Limited Liability Company "Sfera-Med"
Saint Petersburg, Russia
Research Center Eco-safety
Saint Petersburg, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.